New and First Ever Chest Pain Guidelines Released

New and First Ever Chest Pain Guidelines Released Posted By:
...

There's exciting news in the world of cardiovascular medicine! A multi-joint medical society (2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR) has published the "Guideline for the Evaluation and Diagnosis of Chest Pain." The announcement was released on October 28, 2021—shedding new light to directly address the needs of evaluation and treatment of patients who present with chest pain.

Based on countless studies, data, and input from numerous medical societies, the guideline will help all practitioners utilize the most updated science to appropriately risk-stratify, evaluate, and treat patients. Key highlights released from this announcement focus on accompanying symptoms of chest pain and the importance of ensuring early care in every setting. In addition, the guidelines address the sometimes-confusing testing and evaluation options for patients with chest pain, including high-sensitivity troponins and imaging modalities. This comprehensive consensus guideline will help many clinicians who see patients with chest pain in clinics, urgent cares, emergency departments, and elsewhere. For more information on this exciting new release, view the report on the JACC website.

References
  • Writing Committee Members, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021. [epub ahead of print].

Share

Filed under: Cardiometabolic

Related
Atrial Fibrillation: Optimizing Outcomes by Addressing Social Determinants of Health and Implicit Bias

Atrial Fibrillation: Optimizing Outcomes by Addres ...

Atrial fibrillation (AF) is the most common sustained arrhythmia diagnosed, and its prevalence is ex ...

Filed under: Cardiometabolic, NPs & PAs


Continue Reading
My Experience With GLP-1 Receptor Agonists in Patients With Type 2 Diabetes

My Experience With GLP-1 Receptor Agonists in Pati ...

When considering the benefits of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) for our pat ...

Filed under: Cardiometabolic, NPs & PAs


Continue Reading
Dietary Sodium Restriction in Patients With Heart Failure

Dietary Sodium Restriction in Patients With Heart ...

There are about 6.2 million adults in the United States living with heart failure (HF), according to ...

Filed under: Cardiometabolic, Pulmonary Medicine


Continue Reading
Bleeding Risk with Apixaban and Systemic Fluconazole Use

Bleeding Risk with Apixaban and Systemic Fluconazo ...

We, as healthcare professionals, are aware that we must check for drug interactions in our patients ...

Filed under: Cardiometabolic, Pulmonary Medicine


Continue Reading
Cardiovascular Risk in Rheumatic Inflammatory Disease

Cardiovascular Risk in Rheumatic Inflammatory Dise ...

It is well documented that those with rheumatic inflammatory diseases have an increased risk of card ...

Filed under: Cardiometabolic, Rheumatology


Continue Reading
The Latest on Heart Failure: Clinical Trials Summary

The Latest on Heart Failure: Clinical Trials Summa ...

Too often, we are faced with hectic workdays that lead into hectic home lives—when we clock ou ...

Filed under: Cardiometabolic


Continue Reading